BioLineRx (BLRX) Interest Coverage Ratio (2013 - 2025)
BioLineRx (BLRX) recorded quarterly Interest Coverage Ratio of 12.09 in Q4 2025, up 66.57% quarter-over-quarter from 7.26 in Q3 2025, and up 1124.04% on a YoY basis from 0.99 in Q4 2024.
BioLineRx (BLRX) Interest Coverage Ratio (2013 - 2025) Analysis & Trends
BioLineRx's Interest Coverage Ratio history runs 13 years deep, the most recent figure standing at 12.09 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 1124.04% year-over-year to 12.09; the TTM figure through Dec 2025 stood at 8.04 (up 259.11% YoY), while the FY2025 annual figure was 8.04, up 259.11% from the prior year.
- Interest Coverage Ratio was 12.09 for Q4 2025 at BioLineRx, up from 7.26 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 32.68 in Q1 2022 to a low of 19.92 in Q4 2023.
- Historically, Interest Coverage Ratio has averaged 12.22 across 5 years, with a median of 8.95 in 2023.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio plunged 414.54% in 2023, then soared 1124.04% in 2025.
- A 5-year view of Interest Coverage Ratio shows it stood at 32.34 in 2021, then plunged by 80.42% to 6.33 in 2022, then slumped by 414.54% to 19.92 in 2023, then jumped by 104.96% to 0.99 in 2024, then jumped by 1124.04% to 12.09 in 2025.
- The last three Interest Coverage Ratio figures came in at 12.09 (Q4 2025), 7.26 (Q3 2025), and 8.34 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | 12.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.09 |
| Sep 30, 2025 | 7.26 |
| Jun 30, 2025 | 8.34 |
| Mar 31, 2025 | 5.69 |
| Dec 31, 2024 | 0.99 |
| Sep 30, 2024 | 3.32 |
| Jun 30, 2024 | 2.77 |
| Mar 31, 2024 | 5.19 |
| Dec 31, 2023 | -19.92 |
| Sep 30, 2023 | 14.76 |
| Jun 30, 2023 | 7.42 |
| Mar 31, 2023 | 9.55 |
| Dec 31, 2022 | 6.33 |
| Sep 30, 2022 | 26.51 |
| Jun 30, 2022 | 20.06 |
| Mar 31, 2022 | 32.68 |
| Dec 31, 2021 | 32.34 |
| Sep 30, 2021 | 23.82 |
| Jun 30, 2021 | 26.91 |
| Mar 31, 2021 | 18.22 |